Temferon demonstrated potential in glioblastoma treatment, with long-term survivors and improved survival rates compared to historical data. The therapy reprograms the tumor microenvironment, inducing ...
About 90% of patients with advanced melanoma who had a complete response to first-line immune checkpoint inhibitors survived more than 3 years, with survival curves plateauing over time, a large ...
Background Socioeconomic deprivation has been associated with adverse outcomes after aortic surgery, although evidence ...
A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukemia (AML) by helping doctors identify if they might relapse up to three months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results